|
Volumn 14, Issue 14, 1996, Pages 1327-1330
|
Adjuvancy and reactogenicity of N-acetylglucosaminyl-N-acetylmuramyl-dipeptide (GMDP) orally administered just prior to trivalent influenza subunit vaccine. A double-blind placebo-controlled study in nursing home residents
a a b b c c d d a a |
Author keywords
Adjuvant; GDMP; Influenza vaccine
|
Indexed keywords
INFLUENZA VACCINE;
MURAMYL DIPEPTIDE DERIVATIVE;
N ACETYLGLUCOSAMINYL N ACETYLMURAMYLDIPEPTIDE;
PLACEBO;
UNCLASSIFIED DRUG;
ADJUVANT THERAPY;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEVER;
HUMAN;
INFLUENZA;
INTRAMUSCULAR DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALAISE;
MORTALITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VACCINATION;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, ORAL;
ANTIBODIES, VIRAL;
DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INFLUENZA VACCINES;
MALE;
NURSING HOMES;
PLACEBOS;
|
EID: 8044245915
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(96)00075-8 Document Type: Article |
Times cited : (6)
|
References (4)
|